Cullinan Management, Inc. ( ($CGEM) ) has released its Q1 earnings. Here is a breakdown of the information Cullinan Management, Inc. presented to ...

The government study provides the most complete picture yet of early-onset cancers, finding the largest increases in four ...

Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat rheumatoid arthritis to initiate in Q2 2025 CLN-978 expands into Sjögren's disea ...

As a leader in T cell engager development for autoimmune diseases, we continue to rapidly advance our global clinical development of CLN-978 in ...

Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat ...

For the past 7 years, Bayer has shelled out billions of dollars in lawsuits brought by people claiming they developed cancer after exposure to its glyphosate-containing weed killers, including its ...